Latest S-1 registration statements

Edible Garden AG Incorporated is offering up to 4,672,898 units, each consisting of one share of common stock or one pre-funded warrant and one warrant, to raise up to $5 million in gross proceeds.

Tianci International, Inc. is pursuing a public offering of 2,170,000 shares of common stock to fund logistics promotion, working capital, and talent recruitment, contingent upon Nasdaq Capital Market approval.

CO2 Energy Transition Corp., a blank check company targeting the carbon capture industry, has filed an amendment to its S-1 registration statement for a proposed $60 million initial public offering.

Rocky Mountain Chocolate Factory is registering for the resale of 1,250,000 shares of common stock by selling stockholders following a recent private placement.

ANEW Medical is registering for resale up to 21.5 million shares of its common stock, including shares issuable upon warrant exercises and shares held by selling stockholders.

Seaport Entertainment Group is offering stockholders the opportunity to purchase up to 7,000,000 shares at $25 each through a rights offering, backstopped by Pershing Square to ensure full subscription.

Enveric Biosciences has filed a registration statement for the resale of up to 4.9 million shares of its common stock by Lincoln Park Capital Fund, potentially generating gross proceeds of $2.45 million.

Cortigent, a neurostimulation technology company, is seeking to raise $15 million through an initial public offering to fund the development of its Orion visual prosthesis and stroke recovery system.

Jupiter Neurosciences aims to raise capital through an IPO to fund the development of its Parkinson's drug, JOTROL, and expand its business operations in Southeast Asia.

Conduit Pharmaceuticals files an S-1 registration statement for the resale of up to 22,004,465 shares of common stock issued to AstraZeneca and Nirland Limited.

Lottery.com plans to reignite its operations with a primary offering of 50,000,000 shares of common stock at $3.00 per share, while also registering shares for selling securityholders.

Mach Natural Resources LP plans to offer 7,853,403 common units to fund acquisitions and for general partnership purposes.

Jupiter Neurosciences is seeking to raise capital through an IPO to advance its JOTROL drug, particularly for Parkinson's disease, and expand into the South-East Asian market.

Jet.AI Inc. is planning to offer shares of its common stock and warrants in a firm commitment offering.

Zapata Computing seeks to raise up to $10 million through a stock resale agreement with Lincoln Park Capital, as detailed in a recent S-1 filing.

PACS Group, a leading post-acute healthcare company, is undertaking a secondary offering of common stock to repay debt and support future expansion.

Oragenics, Inc. announces a public offering of common stock and pre-funded warrants to raise up to $5 million for its ONP-002 concussion treatment and general corporate purposes.

UL Solutions Inc. announces a secondary offering of 20 million shares of Class A common stock by selling stockholder UL Standards & Engagement.

BioAge Labs, a clinical-stage biopharmaceutical company, has filed for an initial public offering to advance its pipeline of therapeutics targeting metabolic diseases by leveraging insights into the biology of human aging.

Bitech Technologies Corporation files an amended S-1 registration statement for a proposed offering of common stock and pre-funded warrants, aiming for a Nasdaq listing.

AgEagle Aerial Systems plans to offer units consisting of common stock and warrants to raise up to $12 million for debt repayment and general corporate purposes.

Bicara Therapeutics advances its IPO plans with an amended S-1 filing, detailing its bifunctional antibody therapy and upcoming clinical trials.

Jet.AI Inc. is filing an amendment to its registration statement for the resale of up to 12.1 million shares of common stock by a selling stockholder.

Aptevo Therapeutics is launching a public offering to sell shares of common stock, pre-funded warrants, and common warrants, aiming to raise capital for clinical programs and general corporate purposes.

Safe and Green Development Corporation is registering for resale up to 29.6 million shares of common stock by selling stockholders, primarily related to convertible debentures and warrants issued to Arena Investors.

MBX Biosciences advances its IPO plans with an amendment, highlighting clinical trial progress and financial details.

Oklo Inc. files an amendment to its S-1 registration statement, potentially allowing selling securityholders to resell up to 62,440,080 shares of Class A Common Stock.

Asset Entities Inc. has filed an amendment to its Form S-1 registration statement to allow for the potential resale of up to 512,920 shares of Class B Common Stock by selling stockholders.

Health In Tech, an insurance technology platform company, files an S-1 registration statement for an IPO, seeking to transform the healthcare industry with its innovative marketplace.

Catheter Precision, Inc. has filed a registration statement to offer common stock units, pre-funded units, and underwriter warrants totaling $564,834.